# Fludrocortisone for Sudden Hearing Loss

> **NCT01186185** · EARLY_PHASE1 · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 5 (actual)

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DRUG:** Fludrocortisone

## Key facts

- **NCT ID:** NCT01186185
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** PI moved to new institution, unable to complete study
- **Last updated:** 2019-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186185, "Fludrocortisone for Sudden Hearing Loss". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01186185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*